阅读说明：本技术 一种抗菌聚乳酸纳米纤维及其制备方法和应用 (Antibacterial polylactic acid nanofiber and preparation method and application thereof ) 是由 廖岚 魏俊超 占莉琳 张凤 张显华 于 2019-10-31 设计创作，主要内容包括：本发明公开了一种抗菌聚乳酸纳米纤维及其制备方法和应用,属于生物医用材料技术领域。本发明通过层层组装的方法,将聚乳酸纳米纤维在多巴胺水溶液中浸泡,形成表面含有聚多巴胺的聚乳酸纳米纤维,然后再浸入氧化锌水分散液中浸泡,形成氧化锌包覆的聚乳酸纳米纤维；通过多次重复上述浸泡过程,可以获得不同氧化锌含量的聚乳酸纳米纳米复合材料。该方法简单、易行,得到的聚乳酸复合材料具有很好的抗菌性能及良好的生物相容性。(The invention discloses an antibacterial polylactic acid nanofiber and a preparation method and application thereof, and belongs to the technical field of biomedical materials. The invention adopts a layer-by-layer assembly method to soak polylactic acid nano fibers in dopamine aqueous solution to form polylactic acid nano fibers with the surface containing polydopamine, and then the polylactic acid nano fibers are soaked in zinc oxide aqueous dispersion to form zinc oxide coated polylactic acid nano fibers; by repeating the soaking process for many times, the polylactic acid nano composite materials with different zinc oxide contents can be obtained. The method is simple and easy to implement, and the obtained polylactic acid composite material has good antibacterial performance and good biocompatibility.)

1. An antibacterial polylactic acid nanofiber, which is characterized in that: the coating comprises a polylactic acid nanofiber substrate and one or more layers of adhesion coatings coated on the polylactic acid nanofiber substrate, wherein zinc oxide nanoparticles are adsorbed on the adhesion coatings.

2. The antimicrobial polylactic acid nanofiber according to claim 1, wherein: the mass percentage of the zinc oxide nano-particles in the antibacterial polylactic acid nano-fiber is 0.9-13.2%.

3. The antimicrobial polylactic acid nanofiber according to claim 1, wherein: the adhesion coating is preferably polydopamine and is formed by oxidative self-polymerization of dopamine monomers.

4. The antimicrobial polylactic acid nanofiber according to claim 1, wherein: the number of the adhesion coating layers is not more than 8.

5. The method for preparing antibacterial polylactic acid nanofibers according to claim 3, wherein: the method comprises the following steps:

A. at normal temperature, placing polylactic acid nanofiber (PLA) in alkaline dopamine aqueous solution to be soaked for 1-10 min, enabling dopamine to be polymerized automatically, and forming polydopamine-coated polylactic acid nanofiber PLA @ PDA;

B. cleaning the surface of the PLA @ PDA obtained in the step A;

C. placing the PLA @ PDA cleaned in the step B into a zinc oxide nanoparticle water dispersion liquid to be soaked for 1-10 min;

D. cleaning the surface of the modified fiber obtained after soaking in the step C;

E. and D, repeating the step A, B, C, D on the modified fiber cleaned in the step D in sequence to obtain the antibacterial polylactic acid nanofiber PLA @ PDA @ ZnO with different zinc oxide contents, wherein: the number of repetitions is 0 to 7.

6. The method for preparing antibacterial polylactic acid nanofibers according to claim 5, wherein: and B, in the step A, the concentration of the dopamine monomer in the dopamine aqueous solution is 0.1-10 mg/mL.

7. The method for preparing antibacterial polylactic acid nanofibers according to claim 5, wherein: the pH value of the alkaline dopamine aqueous solution in the step A is preferably 8.0-9.0.

8. The method for preparing antibacterial polylactic acid nanofibers according to claim 5, wherein: and B, the concentration of zinc oxide in the aqueous dispersion of the zinc oxide nano particles in the step B is 0.1-10 mg/mL.

9. The use of the antibacterial polylactic acid nanofibers according to any one of claims 1 to 4 or the antibacterial polylactic acid nanofibers prepared by the method according to any one of claims 5 to 8, wherein: can be used in bone tissue repair materials or guided bone tissue regeneration membranes.

Technical Field

The invention belongs to the technical field of biomedical materials, particularly relates to a bone tissue repair material with an antibacterial function, and more particularly relates to polylactic acid nano fibers with an antibacterial function, and a preparation method and application thereof.

Background

Infection caused by bacteria is a main cause of failure of the biomaterial implanted into the body, and thus imparting excellent antibacterial properties to the biomaterial has a very important value for clinical applications.

Polylactic acid (PLA) is an important biodegradable polymer material, has good biocompatibility, controllable degradation rate and excellent mechanical strength, and has been extensively studied in the biomedical fields of surgical sutures, drug controlled release, tissue engineering, orthopedic fixation materials, GBR barrier membranes, and the like. However, polylactic acid has no antibacterial property and faces the problem of bacterial infection in application.

Compounding a material having an antibacterial function with polylactic acid is an effective method for achieving the antibacterial function thereof. However, common antibacterial materials such as nano Ag have biotoxicity, antibacterial peptide is easy to inactivate, and antibiotics easily cause bacterial drug resistance. The zinc oxide is a kind of antibacterial material with good biocompatibility and has been applied in clinic, but how to load the zinc oxide on the surface of the polylactic acid nanofiber and effectively control the load of the polylactic acid nanofiber so as to fully exert the antibacterial performance of the polylactic acid nanofiber has not been reported.

For the above reasons, the present application has been made.

Disclosure of Invention

In view of the problems or defects of the prior art, the present invention aims to provide a polylactic acid nanofiber with antibacterial function, and a preparation method and applications thereof. According to the invention, the bionic and layer-by-layer assembly method of the mussels is adopted, the zinc oxide is loaded on the surface of the polylactic acid nanofiber, and the polylactic acid nanofibers with different antibacterial properties can be obtained by controlling the number of assembly layers.

In order to achieve the first object of the present invention, the present invention adopts the following technical solutions:

the antibacterial polylactic acid nanofiber comprises a polylactic acid nanofiber substrate and one or more layers of adhesion coatings coated on the polylactic acid nanofiber substrate, wherein zinc oxide nanoparticles are adsorbed on the adhesion coatings.

Further, in the technical scheme, the mass percentage of the zinc oxide nanoparticles in the antibacterial polylactic acid nanofibers is 0.9-13.2%.

Further, in the above technical solution, the adhesion coating is preferably polydopamine, and is formed by oxidative self-polymerization of dopamine monomer.

Further, according to the technical scheme, the number of the adhesion coating layers is not more than 8.

The second object of the present invention is to provide a method for preparing the antibacterial polylactic acid nanofibers, comprising the following steps:

A. at normal temperature, placing polylactic acid nanofiber (PLA) in alkaline dopamine aqueous solution to be soaked for 1-10 min, enabling dopamine to be polymerized automatically, and forming polydopamine-coated polylactic acid nanofiber PLA @ PDA;

B. cleaning the surface of the PLA @ PDA obtained in the step A;

C. placing the PLA @ PDA cleaned in the step B into a zinc oxide nanoparticle water dispersion liquid to be soaked for 1-10 min;

D. cleaning the surface of the modified fiber obtained after soaking in the step C;

E. and D, repeating the step A, B, C, D on the modified fiber cleaned in the step D in sequence to obtain the antibacterial polylactic acid nanofiber PLA @ PDA @ ZnO with different zinc oxide contents, wherein: the number of repetitions is 0 to 7.

Specifically, in the above technical scheme, the normal temperature refers to a natural room temperature condition in four seasons, no additional cooling or heating treatment is performed, and the normal temperature is generally controlled to be 10-30 ℃, preferably 15-25 ℃.

Further, according to the technical scheme, the concentration of the dopamine monomer in the dopamine aqueous solution in the step A is 0.1-10 mg/mL, and preferably 2 mg/mL.

Further, in the technical scheme, the alkaline dopamine aqueous solution in the step A is preferably a weak alkaline aqueous solution, and the pH value of the alkaline dopamine aqueous solution is preferably 8.0-9.0.

Further, in the above technical solution, in the aqueous dispersion of zinc oxide nanoparticles in step B, the concentration of zinc oxide is 0.1-10 mg/mL, preferably 1 mg/mL.

The third purpose of the present invention is to provide the application of the antibacterial polylactic acid nanofiber, which can be used in bone tissue repair materials or guided bone tissue regeneration membranes.

Compared with the prior art, the polylactic acid nano fiber with the antibacterial function, the preparation method and the application thereof have the following beneficial effects:

(1) according to the invention, the composite material with an antibacterial function is obtained by loading the zinc oxide nano particles on the surface of the polylactic acid nano fiber, and the material has good antibacterial performance and biocompatibility, and has good application prospects in biomedical fields such as bone tissue repair and guided bone tissue regeneration membranes.

(2) The preparation method is simple and environment-friendly, the adopted raw materials have no toxic or side effect, and the obtained antibacterial nanofiber has excellent mechanical properties.

Drawings

FIG. 1 is a flow chart of the preparation process of the antibacterial polylactic acid nano fiber of the present invention.

Fig. 2 is a Scanning Electron Microscope (SEM) image of the polylactic acid nanofiber membrane raw material used in each example of the present invention.

In FIG. 3, (A), (B), (C), and (D) are Scanning Electron Microscope (SEM) images of the antibacterial polylactic acid nanofiber membranes prepared in examples 1 to 4, in that order.

In fig. 4, (a), (B), (C), (D), and (E) are graphs showing the results of the antibacterial performance test of the polylactic acid nanofiber (PLA) film raw material adopted by the present invention, and the antibacterial function polylactic acid nanofiber films PLA @ PDA @ ZnOT1, PLA @ PDA @ ZnO T3, PLA @ PDA @ ZnO T5, PLA @ PDA @ ZnO T7 prepared in examples 1 to 4 on staphylococcus aureus in sequence.

FIG. 5 is a comparison graph of results of biocompatibility evaluation of polylactic acid nanofiber (PLA) membrane raw materials, the antibacterial polylactic acid nanofiber membranes PLA @ PDA @ ZnO T1, PLA @ ZnO @ T3, PLA @ PDA @ ZnO T5, PLA @ PDA @ ZnOT7 prepared in examples 1 to 4, and the PLA @ PDA prepared in comparative example 1, respectively, using osteoblasts.

Detailed Description

The present invention will be described in further detail below with reference to examples. The present invention is implemented on the premise of the technology of the present invention, and the detailed embodiments and specific procedures are given to illustrate the inventive aspects of the present invention, but the scope of the present invention is not limited to the following embodiments.

Various modifications to the precise description of the invention will be readily apparent to those skilled in the art from the information contained herein without departing from the spirit and scope of the appended claims. It is to be understood that the scope of the invention is not limited to the procedures, properties, or components defined, as these embodiments, as well as others described, are intended to be merely illustrative of particular aspects of the invention. Indeed, various modifications of the embodiments of the invention which are obvious to those skilled in the art or related fields are intended to be covered by the scope of the appended claims.

For a better understanding of the invention, and not as a limitation on the scope thereof, all numbers expressing quantities, percentages, and other numerical values used in this application are to be understood as being modified in all instances by the term "about". Accordingly, unless expressly indicated otherwise, the numerical parameters set forth in the specification and attached claims are approximations that may vary depending upon the desired properties sought to be obtained. At the very least, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.

The invention provides the following technical scheme: the polylactic acid nanofiber with the antibacterial function takes the polylactic acid nanofiber as a matrix, and then is subjected to dopamine treatment and zinc oxide dispersion liquid soaking in sequence to obtain the polylactic acid nanofiber with the antibacterial function.

The invention discloses a preparation method of polylactic acid nano fiber with antibacterial function, which comprises the following steps:

A. uniformly immersing polylactic acid nano fibers into an alkaline dopamine aqueous solution; forming a polydopamine layer on the surface of polylactic acid due to dopamine self-polymerization to obtain polydopamine-coated polylactic acid nano fiber (PLA @ PDA);

B. and (C) washing the PLA @ PDA obtained in the step A with water to remove impurities physically adsorbed on the surface.

C. And D, soaking the PLA @ PDA obtained in the step B into the aqueous dispersion of zinc oxide (ZnO).

D. And D, washing the fiber obtained after soaking in the step C with water, and removing impurities physically adsorbed on the surface to obtain the polylactic acid nanofiber (PLA @ PDA @ ZnO) with the antibacterial function.

E. And D, repeating the step A, B, C, D by using the polylactic acid nano fiber obtained in the step D in sequence to obtain the polylactic acid nano fibers with different zinc oxide contents.